Nanoform technology delivers successful results for Herantis CDNF drug candidate

HELSINKI, Sept. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF...

from PR Newswire: https://ift.tt/3nlH3KF